Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
tVNS in POTS
tVNS in POTS

Review Article

Author(s): Praloy Chakraborty , Kassem Farhat , Lynsie Morris , et al Added: 2 years ago

Electrophysiology & Arrhythmia
AF Stroke Prevention
Author(s): Thorsten Hanke Added: 1 year ago
First presented at ESC 2024, this on-demand programme sees Prof Gregory Lip(University of Liverpool, UK) lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten Hanke(Asklepios Klinikum Harburg, DE) andProf Richard Whitlock(McMaster University, CA) review the application of the latest AF guidance in a clinical setting.This case-based programme explores the… View more

Electrophysiology & Arrhythmia
The Future of EP Training: Digital, AI & Hands-On Learning
Author(s): Devi Nair , Nassir F Marrouche , Janet Han Added: 1 year ago
In this episode of Rhythm Interventions Unplugged, host Dr Devi Nair sits down with leading electrophysiologists Dr Nassir Marrouche and Dr Janet Han to explore the future of electrophysiology (EP) training in the digital age. With virtual learning, AI in cardiology, and cutting-edge EP technology transforming education, how are training programs evolving to keep up?From bite-sized digital… View more

Electrophysiology & Arrhythmia
Cardiac Diagnostics in the Age of Artificial Intelligence
Author(s): Klaus Witte, Luca Santini, Alphons Vincent ,et al Start date: May 06, 2025
Join Dr Luca Santini (Rome, IT) and Prof Klaus Witte (Leeds, UK) for an engaging educational webinar exploring the critical importance of sensitivity and specificity in Insertable Cardiac Monitors (ICMs).Discover how reducing false positives impacts sensitivity, why balancing these factors is essential, and what real-world data reveals about achieving clinical accuracy. The session will also… View more

Electrophysiology & Arrhythmia
James Nolan
Professor James Nolan is a Consultant Cardiologist and Professor of Interventional Cardiology, as well as a member of the British Coronary Intervention Society and British Cardiovascular Society. He has particular interest in transradial cardiac procedures and percutaneous coronary intervention. Having published extensively in the field of radial access and percutaneous intervention, Prof… View more
Research Area(s) / Expertise: Job title: Cardiology Registrar
Ablation vs Drugs for VT: Insights from VANISH2
Added: 1 month ago Source:  Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular… View more

MI/ACS

Electrophysiology & Arrhythmia
AF Stroke Prevention: Applying New Guidance in the Real World
Start date: Sep 01, 2024 End date: Sep 01, 2024
Radcliffe Medical Education is hosting a symposium entitled 'AF Stroke Prevention: Applying New Guidance in the Real World' at 15:15 UTC+1 on Sunday 1 September 2024 in Dublin Room atESC 2024, ExCel Centre, London, UK.Add to your calendar.OverviewProf Gregory Lip(University of Liverpool, Liverpool, UK) will lead a faculty comprisingProf Elena Arbelo (University of Barcelona, ES), ProfThorsten… View more

Electrophysiology & Arrhythmia
Long-term Survival in Concomitant Surgical Ablation for AF
Author(s): Mark A Sammut , Justin Lee , Sxe Chang Cheong , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
Rivaroxaban Monotherapy Shows Consistent Benefit Across Age Groups in AF and Stable CAD
Added: 6 months ago Source:  Arrhythmia Academy
Managing antithrombotic therapy in older patients with both atrial fibrillation (AF) and stable coronary artery disease (CAD) presents a clinical challenge, balancing the risks of thrombotic events and bleeding. A new post hoc analysis of the AFIRE trial sought to clarify whether the effects of rivaroxaban monotherapy differ across age groups compared to combination therapy with an antiplatelet… View more

Anticoagulation

Demographic